The four most worrying coronavirus variants have been detected in virtually all countries and territories of the Americas, but although they are more transmissible there is no evidence they are more lethal, a World Health Organization expert said on Thursday.
The vaccines that are being administered in the region do provide more protection against the variants, Jairo Mendez, a WHO infectious diseases expert said in a webinar by the Pan American Health Organization (PAHO).
Read the latest updates in our dedicated coronavirus section.
“What we still do not know is whether fully vaccinated people who do not become ill can still spread the virus to others. We have a lot to learn,” Mendez said.
The newest variant, the Indian B.1.617 variant, has been detected in cases in eight countries of the Americas, including Canada and the US, he said.
One case is under investigation, and others with the variants were travelers in Panama and Argentina who had arrived from India or Europe. In the Caribbean, cases of the Indian variant have been detected in Aruba, Dutch St Maarten and the French department of Guadeloupe.
The B.117 prevalent in the United Kingdom has been found in cases reported in 34 countries or territories in the Americas, while the South African variant B.1.351 has been reported in 17.
Brazil’s so-called Manaus variant P.1 has so far been detected in 21 countries, the WHO expert said.
“These variants have a greater capacity for transmission, but so far we have not found any collateral consequences,” Mendez said. “The only worry is that they spread faster.”
The variants are associated with higher mortality due to the increased number of cases of COVID-19 but not because the virus has mutated into a more lethal version, he said.
Read more:
UAE approves Pfizer COVID-19 vaccine for emergency use in 12-15 year olds
Indian states turn to anti-parasitic drug to fight COVID-19 against WHO advice
Amazon to hire 75,000 workers, offers $100 extra for COVID-19 vaccination proof
-
UAE approves Pfizer COVID-19 vaccine for emergency use in 12-15 year olds
The United Arab Emirates has approved the Pfizer and BioNTech COVID-19 vaccine for emergency use in children aged 12-15, the government said on ... Coronavirus -
Indian states turn to anti-parasitic drug to fight COVID-19 against WHO advice
At least two Indian states have said they plan to dose their populations with the anti-parasitic drug ivermectin to protect against severe COVID-19 ... Coronavirus -
Amazon to hire 75,000 workers, offers $100 extra for COVID-19 vaccination proof
Amazon.com Inc will give $100 more to new hires with proof of COVID-19 vaccination, the world’s largest e-commerce retailer said on Thursday, as part ... Economy